These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 806076)

  • 61. Considerations for Laboratory Biosafety and Biosecurity During the Coronavirus Disease 2019 Pandemic: Applying the ISO 35001:2019 Standard and High-Reliability Organizations Principles.
    Callihan DR; Downing M; Meyer E; Ochoa LA; Petuch B; Tranchell P; White D
    Appl Biosaf; 2021 Sep; 26(3):113-122. PubMed ID: 36035545
    [No Abstract]   [Full Text] [Related]  

  • 62. Addressing Conflicts of Interest and Conflicts of Commitment in Public Advocacy and Policy Making on CRISPR/Cas-Based Human Genome Editing.
    Christian A
    Front Res Metr Anal; 2022; 7():775336. PubMed ID: 35572153
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Genetic/genomic testing: defining the parameters for ethical, legal and social implications (ELSI).
    Ascencio-Carbajal T; Saruwatari-Zavala G; Navarro-Garcia F; Frixione E
    BMC Med Ethics; 2021 Nov; 22(1):156. PubMed ID: 34814901
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Opinion: Toward inclusive global governance of human genome editing.
    Yu H; Xue L; Barrangou R; Chen S; Huang Y
    Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34789569
    [No Abstract]   [Full Text] [Related]  

  • 65.
    Madzak C
    J Fungi (Basel); 2021 Jul; 7(7):. PubMed ID: 34356927
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Development of a Biocontained Toluene-Degrading Bacterium for Environmental Protection.
    Ishikawa M; Kojima T; Hori K
    Microbiol Spectr; 2021 Sep; 9(1):e0025921. PubMed ID: 34319138
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Insights of Radical Science in the CRISPR Gene-Editing Era: A History of Science for the People and the Cambridge Recombinant DNA Controversy.
    Botelho A
    Sci Cult (Lond); 2021; 30(1):74-103. PubMed ID: 34239225
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Plasma Proteomes Can Be Reidentifiable and Potentially Contain Personally Sensitive and Incidental Findings.
    Geyer PE; Mann SP; Treit PV; Mann M
    Mol Cell Proteomics; 2021; 20():100035. PubMed ID: 33444735
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Engineered fluoride sensitivity enables biocontainment and selection of genetically-modified yeasts.
    Yoo JI; Seppälä S; OʼMalley MA
    Nat Commun; 2020 Oct; 11(1):5459. PubMed ID: 33122649
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of the use of untargeted metabolomics in the safety assessment of genetically modified crops.
    Bedair M; Glenn KC
    Metabolomics; 2020 Oct; 16(10):111. PubMed ID: 33037482
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Controlling the Implementation of Transgenic Microbes: Are We Ready for What Synthetic Biology Has to Offer?
    Stirling F; Silver PA
    Mol Cell; 2020 May; 78(4):614-623. PubMed ID: 32442504
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Safe-by-Design: Stakeholders' Perceptions and Expectations of How to Deal with Uncertain Risks of Emerging Biotechnologies in the Netherlands.
    Bouchaut B; Asveld L
    Risk Anal; 2020 Aug; 40(8):1632-1644. PubMed ID: 32421209
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Regulation of Synthetic Biology: Developments Under the Convention on Biological Diversity and Its Protocols.
    Keiper F; Atanassova A
    Front Bioeng Biotechnol; 2020; 8():310. PubMed ID: 32328486
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Innovation in biosafety oversight: The Harvard Catalyst Common Reciprocal IBC Reliance Authorization Agreement.
    Caruso R; Myatt T; Bierer BE
    J Clin Transl Sci; 2020 Apr; 4(2):90-95. PubMed ID: 32313697
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genomic research delivering on promises: From rejuvenation to vaccines and pharmacogenetics.
    Li Wan Po A
    J Clin Pharm Ther; 2020 Jun; 45(3):585-589. PubMed ID: 32187712
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Of Molecules and Mechanisms.
    Benson DL
    J Neurosci; 2020 Jan; 40(1):81-88. PubMed ID: 31630114
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multi-cellular engineered living systems: building a community around responsible research on emergence.
    Sample M; Boulicault M; Allen C; Bashir R; Hyun I; Levis M; Lowenthal C; Mertz D; Montserrat N; Palmer MJ; Saha K; Zartman J
    Biofabrication; 2019 Jul; 11(4):043001. PubMed ID: 31158828
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Selection, Addiction and Catalysis: Emerging Trends for the Incorporation of Noncanonical Amino Acids into Peptides and Proteins in Vivo.
    Mayer C
    Chembiochem; 2019 Jun; 20(11):1357-1364. PubMed ID: 30618145
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Policy and Governance Perspectives for Regulation of Genome Edited Crops in the United States.
    Wolt JD; Wolf C
    Front Plant Sci; 2018; 9():1606. PubMed ID: 30467510
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Devices of Responsibility: Over a Decade of Responsible Research and Innovation Initiatives for Nanotechnologies.
    Shelley-Egan C; Bowman DM; Robinson DKR
    Sci Eng Ethics; 2018 Dec; 24(6):1719-1746. PubMed ID: 29019058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.